Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH)
AMPH Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
27.20%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
36%
AMPH Stock Analysis
AMPH
PE Ratio:
10.9
AMPH
PEG Ratio:
0.6
AMPH
Forward EPS Growth (12 month):
19.00%
AMPH
PS Ratio:
1.1
AMPH
PSG Ratio:
0.2
AMPH
Forward Revenue Growth (12 month):
5.60%
AMPH Articles
No data was found